Table 2B.
Negative predictive values for HDs (n = 285)
| Positive | bRPA2 (>1731)* | Total | ||
|---|---|---|---|---|
| Positive | Negative | |||
| PDCD11 (>13,921)** | Positive | 63 | 63 | 126 |
| Negative | 27 | 132 | 159 | |
| Total | 90 | 195 | 285 | |
Either bRPA2-Ab or PDCD11-Ab levels were elevated in 73 patients with TIA (n = 92). Both of antibody levels were not elevated in 19 patients with TIA and 132 HDs (total = 151).
*
RPA2, elevated RPA2-Ab levels. RPA2-Ab cut-off was 1731 based on ROC curve analysis.
**
PDCD11, elevated PDCD11-Ab levels. PDCD11-Ab cut-off was 13921 based on ROC curve analysis.